CD274 and non-small cell lung carcinoma: The maintenance of non-PD after four cycles of platinum-based chemotherapy showed a strong relationship with the longer OS associated with subsequent ICI monotherapy for patients with NSCLC with PD-L1 expression of 1–49%.